News
Avatar worms help to identify factors that modify genetic diseases
IDIBELL researchers have used gene-editing technology in C. elegans to reproduce human mutations that cause retinitis pigmentaria. With this method, they have studied factors that affect disease development and possible drug treatments. Often, patients from the same family and carriers of the same genetic mutation, develop a disease differently. This disparity may be due […]
3rd SLHAM of women scientists of IDIBELL arrives
The 3rd SLHAM of women scientists will take place on Saturday, February 8 at 7 pm at the Auditori Barradas, in L’Hospitalet. Nine women researchers and professionals from the Bellvitge Biomedical Research Institute (IDIBELL) will participate. Each of them will explain their work concerning research and innovation through a five-minute informative talk. The 2020 edition […]
Three IDIBELL researchers receive funding from the EU H2020 program
Three IDIBELL researchers have received funding from the European Union to develop research projects within the framework of the Work Program on Health of Social Challenges, in the context of the Horizon 2020 research and innovation program, in its 2019 call. H2020 is an extremely competitive research program, with a strong focus on excellence, innovation […]
The Christmas concert of L’Hospitalet and IDIBELL closes the first edition of the campaign Save lives and the 15th anniversary of the Institute
On December 20th, the Joventut Theater hosted the extraordinary Christmas concert of L’Hospitalet and IDIBELL, starring this year by the Vallès Symphony Orchestra. About 500 spectators enjoyed a show that, as it is traditional, had a solidarity character, since all the raised money will go to biomedical research, specifically, to cancer research projects led by […]
Gabriel Capellá takes stock of the year in the IDIBELL transparency session
IDIBELL has held its annual transparency session, by the director of the institution, Dr. Gabriel Capellá. Before an audience of 170 people, gathered in the Pau Viladiu Conference Hall of the Duran i Reynals Hospital, Capellá has pointed the various items of a detailed and exhaustive report that, in summary, has laid special emphasis on […]
Researchers at ICO and IDIBELL participate in an international study that measures the impact of cervical cancer elimination goals
By 2030, 90% of girls should be vaccinated, 70% of women screened, and 90% of women with precancerous lesions treated
State of ‘hibernation’ keeps haematopoietic stem cells young
All tissues age. The blood-forming system is especially affected by ageing processes. Haematopoietic stem cells, the precursors to blood and immune cells, age exceptionally fast, losing the ability to divide and regenerate. This weakens the immune system and increases the risk of blood cancer. An international team led by researchers from Ulm and Barcelona has […]
An IDIBELL and UB research team demonstrates the involvement of glucose in the growth of tumor cells
Tumors take a great energy expenditure to grow and proliferate. Cancer cells are, in fact, addicted to the main fuel of cellular metabolism, glucose. The molecular machinery that degrades this sugar for energy (the so-called glycolytic enzymes) is overexpressed in tumor cells. But this is not the only characteristic that differentiates the metabolism of tumor […]
IDIBELL and Alba Pérez Foundation take a new step forward to develop a treatment for Ewing’s sarcoma
The Alba Pérez Foundation has signed a framework collaboration agreement with the Bellvitge Biomedical Research Institute that aims to support research projects related to Ewing’s sarcoma, an investigation led by Dr. Òscar Martínez-Tirado, head of IDIBELL’s Sarcomas group. Along the same lines, and making a new step forward, both entities have also signed a specific […]